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Corneal scarring is a commonly occurring consequence 
of several forms of trauma, e.g., wounds, chemical burns, 
infections, and refractive surgery. Since refractive surgery 
has become one of the most commonly used surgical proce-
dures worldwide, it is now an important concern that in a 
small percentage of cases, wound repair results in the forma-
tion of a scar, commonly called “haze,” at the center of the 
cornea, which induces a loss of visual acuity. Therapeutic 
tools for preventing or treating corneal haze are presently 
limited [1-3], thus raising an urgent need to better understand 
the mechanisms involved in postoperative recovery.
Epithelial lesions normally resolve within several days, 
without any fibrotic response, due to the migration of stem 
cells from the surrounding limbus [4,5] or from other parts 
of the epithelium [6,7] into the injured region. Only in the 
case of disruption of the epithelial basement membrane can 
pathological evolution of the healing process occur, due 
mainly to fibrogenic factors, such as transforming growth 
factor-β1 (TGF-β1) and TGF-β2 [8], released by the injured 
epithelial cells [9,10], and inflammatory cells [11], into the 
stroma. TGF-β2 is also present in tear f luid [12]. These 
growth factors (and others) trigger the activation of quies-
cent stromal cells (keratocytes) from the wound periphery 
that then repopulate the wound area where resident cells have 
died by apoptosis soon after injury [13]. These activated kera-
tocytes proliferate and undergo phenotypic changes typical 
of myofibroblasts [14] with increased ability to synthesize 
the extracellular matrix and promote wound contraction, 
as evidenced by the expression of α-smooth muscle actin 
(α-SMA). In addition, myofibroblasts themselves produce 
TGF-β [15], thus amplifying the response.
A related consequence of injury is that the turnover 
of the extracellular matrix is accelerated [16]. Among the 
proteins abundantly expressed during the first steps of wound 
healing are cellular fibronectin [17,18] and collagen III [19]. 
At later stages, the provisional matrix is replaced by a tissue 
rich in collagen I with functional properties (fibril diameter, 
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Purpose: To develop ex vivo organ culture models of human corneal scarring suitable for pharmacological testing and 
the study of the molecular mechanisms leading to corneal haze after laser surgery or wounding.
Methods: Corneas from human donors were cultured ex vivo for 30 days, either at the air-liquid interface (AL) or im-
mersed (IM) in the culture medium. Histological features and immunofluorescence for fibronectin, tenascin C, throm-
bospondin-1, and α-smooth muscle actin were graded from 0 to 3 for control corneas and for corneas wounded with an 
excimer laser. The effects of adding 10 ng/ml transforming growth factor-β1 (TGF-β1) to the culture medium and of 
prior complete removal of the epithelium and limbus, thus preventing reepithelialization, were also analyzed on wounded 
corneas. Collagen III expression was detected with real-time PCR.
Results: Wounding alone was sufficient to induce keratocyte activation and stromal disorganization, but it was only in 
the presence of added TGF-β1 that intense staining for fibronectin and tenascin C was found in the AL and IM models (as 
well as thrombospondin-1 in the AL model) and that α-smooth muscle actin became detectable. The scar-like appearance 
of the corneas was exacerbated when TGF-β1 was added and reepithelialization was prevented, resulting in the majority 
of corneas becoming opaque and marked upregulation of collagen III.
Conclusions: The main features of corneal scarring were reproduced in these two complementary models: the AL model 
preserved differentiation of the epithelium and permits the topical application of active molecules, while the IM model 
ensures better perfusion by soluble compounds.
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orientation, and lamellar organization) similar to those of the 
initial tissue. In the case of pathological evolution, markers of 
the provisional matrix persist, and myofibroblasts do not die 
by apoptosis as expected. Other matrix proteins are known to 
play important roles during corneal wound healing, especially 
the proteins that modulate cell-matrix interactions such as 
tenascin C and thrombospondin-1. Tenascin C is transiently 
expressed in the wound periphery [18] and is thought to 
control fibroblast recruitment to the wound area [20]. Its 
persistence is a hallmark of a fibrotic process. Thrombos-
pondin-1 is known to accelerate corneal reepithelialization 
after epithelial injury [21] and to inhibit neoangiogenesis [22], 
thus contributing to maintaining corneal transparency.
Several in vivo and ex vivo models of corneal wound 
healing have been developed in rodents and rabbits with 
various types of wounds: mechanical [10,23,24], alkali burns 
[25], and excimer laser [26,27]. However, rodents heal faster 
than humans with a reduced tendency to develop scars. In 
this respect, rabbits are more similar to humans, but the panel 
of available tools (gene sequences, antibodies, small inter-
fering RNAs, etc.) is reduced. In addition, the differences 
in Bowman’s membrane and stromal organization between 
rodents, rats, and humans [28] could potentially lead to 
differences in repair mechanisms. Thus, there is a need to 
develop ex vivo models of human corneal scarring, capable 
of reproducing as many features as possible of the in vivo 
situation, for testing novel therapeutic agents. Several such 
ex vivo models have been described [29-35], though these 
are mainly concerned with the process of reepithelialization, 
and only limited studies on markers of wound healing have 
been performed [30,34,36]. In particular, none of the ex vivo 
models described has been shown to develop the opacity that 
is characteristic of corneal scarring or haze.
Here we describe two ex vivo models of corneal scar-
ring, using human donor corneas rejected for keratoplasty. 
Wounds were created using an excimer laser, to mimic refrac-
tive corneal surgery, and then corneas were cultured in either 
immersed conditions or raised to the air-liquid interface, for 
30 days. We tested the effects of the epithelium/limbus and 
of exogenous TGF-β1 on the wound healing process, with 
histology and immunofluorescence for markers of keratocyte 
differentiation (α-smooth muscle actin) and wound healing 
(fibronectin, tenascin C, thrombospondin-1), and with real-
time PCR analysis for expression of collagen III. For the first 
time, we established conditions leading to the development of 
corneal opacity (absence of epithelium/limbus and presence 
of exogenous TGF-β1). In addition, we obtained models of 
intermediate severity when one or more of these parameters 
were changed. This system therefore appears sufficiently 
versatile for testing novel therapeutic agents.
METHODS
Cornea collection from the cornea bank: Corneas from 
human donors (ages 40–80) were collected in agreement 
with the tenets of the Declaration of Helsinki, including the 
consent of families for clinical and scientific use, and then 
stored in the cornea bank of the Hôpital E. Herriot (Lyon, 
France), at 31 °C in organ culture medium, for a maximum of 
21 days before use. Since corneas were collected for grafting 
purposes, patient selection followed a rigorous set of criteria, 
as defined by the French Agence de la Biomedicine in 
conjunction with the Hospices Civils de Lyon. These include 
absence of viral, bacterial, or parasite infections, low risk of 
Creutzfeldt-Jacob disease, absence of tumors, lack of treat-
ment with immunosuppressants or blood products, unknown 
cause of death, lack of exposure to toxic substances, and 
absence of corneal pathology or corneal surgery. The corneas 
used for the experiments described here were rejected for 
grafting because of low endothelial density.
Epithelium removal and excimer laser treatment: Depending 
on the conditions studied, the corneal epithelium and limbus 
(denoted collectively by E in Figure 1) were sometimes 
removed before culture. In these cases (the W and WT condi-
tions), the epithelium was peeled off using a 6 mm lancet 
shaped Desmarres-Paufique keratoplasty dissector knife 
(Moria, Antony, France) in such a way as to leave the base-
ment membrane intact, and the limbus was removed using 
scissors or a trepan (8 mm). Wounding (denoted by W in 
Figure 1) was performed using an excimer laser (diameter 
4 mm, depth 250 µm).
Ex vivo cultures: Corneas were cultured, for 30 days at 
37 °C in 5% CO
2
 using 10 ml of medium per six-well plate, 
either fully immersed (IM; epithelium uppermost; Figure 
1) or maintained at the air-liquid interface (AL; Figure 1). 
Medium composition was as follows: Dulbecco’s Modified 
Eagle Medium (DMEM)/Glutamax and Ham’s F-12 (both 
from GIBCO/Life Technologies, Saint Aubin, France) mixed 
in a 1:1 ratio with 10% fetal bovine serum (Hyclone/Thermo 
Fisher Scientific, Brebières, France), 50 µg/ml vitamin C 
(Bayer, Berlin, Germany), 100 UI/ml penicillin, 20 µg/ml 
streptomycin (Panpharma, Fougères, France), and 1 µg/ml 
Fungizone (Bristol Myers Squibb, Rueil-Malmaison, France). 
The medium was changed three times a week. In some condi-
tions (denoted by T in Figure 1), the medium was supple-
mented with 10 ng/ml TGF-β1 (R & D Systems Europe, 
Lille, France). When cultured at the air-liquid interface, the 
posterior (“endothelial”) face of the cornea was in contact 
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with sterile blotting paper, soaked with culture medium, and 
placed on a conformer to maintain the curved shape of the 
cornea, while the anterior (“epithelial”) face was in contact 
with air (Figure 1). A drop of medium was added twice a 
day either to the top of the cornea or directly into the wound 
(when present) to mimic the effect of tears.
Histological analyses and immunofluorescence: After 30 
days in culture, corneas were cut into two halves: the first 
was fixed with formalin before paraffin inclusion while the 
second was frozen with optimal cutting temperature embed-
ding medium (Tissue Tek). Histology was performed after 
hematoxylin phloxine saffron (HPS) staining. For immu-
nofluorescence, frozen sections (5 µm) were first blocked 
in phosphate buffered saline containing 1% (w/v) bovine 
serum albumin and 5% normal goat serum. Mouse mono-
clonal primary antibodies were used as follows: anti-α-SMA 
(Novocastra, Newcastle-upon-Tyne, UK; dilution 1:100), 
antitenascin C (Dako, Trappes, France; dilution 1:200), antifi-
bronectin (Santa Cruz Biotechnology, Heidelberg, Germany; 
dilution 1:50), antithrombospondin 1 (Thermo Fisher; dilu-
tion 1:100). The secondary antibody was either fluorescein 
isothiocyanate–conjugated sheep antimouse immunoglobulin 
G (IgG) (TEBU Bio, Le Perray en Yvelines, France; dilution 
1:100) or Alexa Fluor 488-conjugated goat antimouse IgG 
(Invitrogen/Life Technologies, Saint Aubin, France; dilution 
1:100). Control IgG was from Abcam (Paris, France). Nuclei 
were stained with 4’,6-diamidino-2-phenylindole (DAPI) 
using Vectashield mounting media for fluorescence (from 
Eurobio/Abcys, Les Ulis, France). Photos were taken with an 
Eclipse 50i optical microscope using NIS-Elements software 
(Nikon, Champigny sur Marne, France).
Immunostaining for collagen III was attempted using 
the following antibodies: goat anticollagen type III (Southern 
Biotech, Birmingham, AL) and mouse anticollagen type III 
(Novotec, Lyon, France). However, although positive results 
on control human skin samples were obtained, the signal 
observed with human corneas was much less satisfactory. 
Thus, collagen III was assessed indirectly by measuring RNA 
levels with real-time PCR (see below).
Semiquantitative evaluation of immunofluorescence was 
performed by three observers independently using a scale 
from 0 to 3, where 0=no staining in the wound area (or central 
Figure 1. Conditions tested in this 
study. A: Details of procedures 
performed before subsequent 
culture, including removal of the 
epithelium and the outer part of 
the cornea including the limbus, 
leaving the epithelial basement 
membrane intact, and wounding 
using an excimer laser. B: Diagram-
matic representation of the different 
culture conditions used, at the 
air-liquid interface (AL) and fully 
immersed in culture medium (IM). 
Conditions include non-wounded 
controls with the epithelium and 
limbus intact (represented by E) 
and wounded corneas (W) with 
and without prior removal of the 
epithelium and limbus, and with 
and without TGF-β1 (T) added at a 
concentration of 10 ng/ml.
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area when no wound was present), 1=presence of stained dots 
in the wound area, 2=marked staining of localized regions 
of the wound, and 3=intense/uniform staining all over the 
wound area. Similarly, the scale used for histology was 0=no 
stromal disorganization, 1=weak stromal disorganization/few 
activated keratocytes, 2=moderate stromal disorganization/
activated keratocytes, and 3=strong stromal disorganization/
numerous activated keratocytes. Statistical significance was 
determined using the Mann–Whitney test, using a p value 
of <0.05.
Real-time polymerase chain reaction detection of collagen 
III: Total RNA was extracted from corneal stromas (after 
the epithelium was removed when present) following culture 
in the IM/E condition (controls; six samples) and the IM/
WT condition (wounding and TGF-β1 in the absence of the 
epithelium and limbus; six samples). Corneas were then 
frozen and transferred from liquid nitrogen to 500 µl RLT 
buffer (RNeasy Mini kit, Qiagen, Courtaboeuf, France)/1% 
β-mercaptoethanol mix and kept on ice. This mix was then 
subjected to eight cycles of 20 s shaking followed by 5 min 
of cooling at 4 °C on a FastPrep-24 System (MP Biomedi-
cals, Illkirch, France). The supernatant was then retrieved, 
and total RNA was extracted and further purified using 
an RNeasy Mini kit and RNase-Free DNase set (Qiagen, 
Courtaboeuf, France). RNA integrity was assessed with a 
2000 Nano Kit (Agilent, Massy, France); each sample used 
had an RNA integrity number of at least 7. Reverse transcrip-
tase PCR was performed using the Invitrogen Superscript 
III VILO kit according to the manufacturer’s recommenda-
tions. Real-time PCR was performed on 2.5 ng cDNA in a 
Roche (Meylan, France) LightCycler 480 using Roche SYBR 
Green I Master mix. Primers were from Eurogentec (Angers, 
France; COL3A1 sense: 5’-GGT GCT CGG GGT AAT GAC 
G-3’; COL3A1 antisense: 5’-TCC AGG GAA TCC GGC AGT 
T-3’). Three genes, already validated for human corneas [37], 
were used as standard baseline genes: TATA box binding 
protein, fibrosin, and PIH1 domain-containing protein 1. PCR 
efficiency was determined for each primer set to calculate 
the expression ratio. The fold-change in gene expression 
was calculated using the 2-ΔΔCT ratio. PCR products were 
checked with sequencing (Millegen, Labege, France).
Evaluation of corneal transparency: Corneal transparency 
was evaluated, after 15 and 30 days, by reading text written 
in Arial characters (8-point font size) through the cornea. 
Corneas were classified as “opaque” when the text could not 
be seen through the cornea.
RESULTS
Using two different experimental configurations, one closer 
to the in vivo situation (corneas cultured at the air-liquid 
interface, denoted by AL in Figure 1) and one that favored 
diffusion of components from the culture medium (immersed 
corneas, denoted by IM in Figure 1), we analyzed the effect 
of three parameters (wounding, addition of TGF-β1, presence 
of epithelium/limbus) for their ability to promote a corneal 
scar-like response. This was evaluated in terms of stromal 
organization and number of activated keratocytes (HPS 
staining), neosynthesis of extracellular matrix components 
(immunofluorescence for fibronectin), expression of specific 
markers of wound healing (immunofluorescence for tenascin 
C and thrombospondin-1), presence of myofibroblasts (immu-
nofluorescence for α-SMA), and transparency (visibility of 
Arial 8-point characters). Since collagen III expression could 
not be detected with immunofluorescence (see Methods), this 
was evaluated indirectly with real-time PCR.
Air-liquid interface model: Figure 2 (the AL/E column) 
shows the characterization of human control corneas cultured 
for 1 month at the air-liquid interface. With HPS staining, 
the stroma showed the lamellar organization typical of the 
cornea, and the epithelium remained differentiated and 
pluristratified. No immunofluorescence for α-SMA or fibro-
nectin was detected. Immunofluorescence for tenascin C was 
sparse. Immunofluorescence for thrombospondin-1 occurred 
in a punctate manner throughout the cornea with a slightly 
more intense signal beneath the basement membrane. None 
of these control corneas were opaque.
To determine if the wound by itself was sufficient to 
trigger a change in the histological appearance of the cornea 
or in the expression of the usual markers of wound healing, 
we compared the control corneas (AL/E) with the wounded 
corneas (AL/WE) cultured in the absence of added TGF-β1. 
Fluorescein staining indicated that complete reepithelializa-
tion was obtained after 7 days in wounded corneas, resulting 
in a pluristratified (five to six layers) epithelium. Bowman’s 
membrane was not reconstituted, as found in in vivo wounds 
[38,39]. Using HPS staining, we observed an increase in the 
number of activated keratocytes, as well as some stromal 
disorganization (Figure 2, the AL/WE column). Semiquanti-
tative evaluation of several samples (Figure 3A) showed this 
increase was significant. Immunofluorescence for fibronectin 
and tenascin C also began to appear (Figure 2, the AL/WE 
column), but these changes were not significant (Figure 3A). 
In contrast, expression of thrombospondin-1 was unchanged 
(compared to the AL/E control) and α-SMA remained unde-
tectable (Figure 2). Wounding alone did not result in corneal 
opacity.
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Since the response to injury alone did not recapitulate all 
the features of wound healing and scarring, especially the lack 
of opacity and the failure of the keratocytes to differentiate 
into α-SMA-expressing myofibroblasts, we next determined 
Figure 2. Corneas cultured at the air-liquid interface. For each condition (E=control with the epithelium and the limbus intact; WE=wounded 
without prior removal of the epithelium and limbus; WET=as WE but with TGF-β1 added at 10 ng/ml; WT=wounded after prior removal 
of the epithelium and limbus plus TGF-β1 added at 10 ng/ml), keratocyte activation (see arrows) and stromal disorganization were assessed 
with hematoxylin phloxine saffron (HPS) staining (scale bars: 100 µm (row 1), 50 µm (row 2)), expression of α-smooth muscle actin (SMA), 
fibronectin (FN), tenascin C (TNC) and thrombospondin-1 (TSP) by immunofluorescence (scale bars=100 µm), and corneal opacity (OP) by 
the ability to read Arial 8 characters (number of opaque corneas/total number of corneas examined for each condition). Each figure shows 
the wound region only, except the control E, which shows the central part of the cornea.
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the effects of adding TGF-β1 to the ex vivo cultured corneas. 
TGF-β1 was added to the medium at a concentration of 10 
ng/ml. Using a single non-wounded control cornea, addition 
of TGF-β1 promoted limited expression of α-SMA, only 
in regions in direct contact with the culture medium (data 
not shown). In contrast, when the wound and TGF-β1 were 
present, α-SMA began to be expressed in the stroma (Figure 
2, the AL/WET column), but this increase was not signifi-
cant (Figure 3A). In addition, keratocyte activation was again 
observed (as for the AL/WE condition) as well as marked 
stromal disorganization, while the number of cell layers in the 
epithelium was slightly decreased in the presence of TGF-β1, 
in agreement with previous reports [24]. Adding TGF-β1 
also led to marked increases in the expression of fibronectin, 
Figure 3. Semiquantitative evalu-
ation of histochemical and immu-
nofluorescence data. A: Corneas 
cultured at the air-liquid interface. 
The total numbers of corneas 
examined per group were: E=3, 
WE=3, WET=7; WT=6. B: Corneas 
cultured in immersed conditions. 
The total numbers of corneas exam-
ined per group were: E=3, WE=3, 
WET=3; WT=4. C: Comparison of 
semiquantitative data for control 
E and wounded corneas (WT; 
wounded after prior removal of 
the epithelium and limbus then 
cultured in the presence of added 
TGF-β1) between the air-liquid and 
immersed conditions. The total 
numbers of corneas examined per 
group were: AL/E=3, IM/E=3, AL/
WT=6; IM/WT=4. In all cases, 
significant differences are indicated 
by * (p<0.05).
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tenascin C, and thrombospondin-1 (compared to the AL/WE 
condition, Figure 2). In contrast, none of the seven corneas 
studied in this condition showed any sign of opacity, as found 
in the absence of TGF-β1 (the AL/E and AL/WE conditions).
We then tested the effect of removing the epithelium and 
limbus before wounding on the repair process (the AL/WT 
condition; Figure 1). Interestingly, in this condition, following 
wounding and the addition of TGF-β1, α-SMA expression was 
now significantly upregulated (Figure 2, the AL/WT column; 
Figure 3A) compared to the control condition (AL/E) and the 
AL/WE and AL/WET conditions. As also found with the 
AL/WET condition, all other parameters (keratocyte activa-
tion and stromal disorganization, expression of fibronectin, 
tenascin C, and thrombospondin-1) remained highly elevated 
(Figure 2; Figure 3A). Most strikingly, for the first time, five 
of the six corneas used for this condition were opaque, as 
illustrated in Figure 4. In contrast, in the absence of added 
TGF-β1, these corneas remained transparent (the AL/W 
condition; data not shown). In addition, even in the presence 
of added TGF-β1, no opacity was seen after 15 days in culture 
(data not shown), indicating that haze first appeared between 
15 and 30 days.
Immersed model: When corneas were cultured in IM condi-
tions, in all cases the epithelium was reduced in thickness, 
as previously reported [33,40], and generally consisted of 
only one cell layer (Figure 5). In control conditions (Figure 
5, column IM/E), the stroma showed a typical lamellar 
organization interspersed with mostly quiescent keratocytes. 
Furthermore, as with the air-liquid equivalent (Figure 2), 
no immunofluorescence staining for α-SMA, fibronectin, 
or tenascin C was detected. Weak staining was seen for 
thrombospondin-1, in the region of the epithelial basement 
membrane, as with the air-liquid equivalent. None of the three 
controls studied were opaque.
Following wounding, but permitting subsequent reepi-
thelialization (the IM/WE condition), with HPS staining acti-
vated keratocytes and stromal disorganization/turgescence 
were seen (Figure 5; the IM/WE column). Semiquantitative 
analysis (Figure 3B) showed this was statistically significant. 
In addition, reepithelialization was complete after 7 days, as 
for the air-liquid equivalent, even though it consisted of a 
single cell layer, unlike the air-liquid equivalent. As with the 
air-liquid equivalent, α-SMA remained undetectable. Immu-
nofluorescence staining for fibronectin and tenascin C was 
however greater than in the air-liquid equivalent, reaching 
statistical significance, compared to the controls (Figure 
3B). Small increases in thrombospondin-1 staining were also 
observed (Figure 5), but these were not significant (Figure 
3B).
Following wounding and with added TGF-β1 (the IM/
WET condition), HPS staining continued to show keratocyte 
activation and stromal disorganization (Figure 5; the IM/
WET column), though with less stromal disorganization 
than in the A/L conditions. As with the air-liquid equivalent, 
α-SMA began to be expressed in this immersed model, but in 
this case the increase was statistically significant (Figure 3B), 
compared to controls. Expression of thrombospondin-1 also 
increased (Figure 5) but not to a significant extent (Figure 
3B). As with the air-liquid equivalent, none of the corneas 
were opaque.
Figure 4. Assessment of corneal 
opacity. While corneas wounded 
without prior removal of the epithe-
lium and the limbus (AL/WE, IM/
WE) are transparent, corneas 
wounded after prior removal of the 
epithelium and limbus and cultured 
with added TGF-β1 (AL/WT, IM/
WT) are opaque. Note that the latter 
corneas are smaller in diameter 
due to the total elimination of the 
limbus by trepanation (8 mm diam-
eter trepan). Scale bars=5 mm.
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Finally, as with the air-liquid model, when the epithe-
lium and limbus were removed before wound healing, and 
in the presence of added TGF-β1, α-SMA expression in the 
immersed IM/WT condition was significantly upregulated 
Figure 5. Corneas cultured in fully immersed conditions. For each condition (E=control with the epithelium and limbus intact; WE=wounded 
without prior removal of the epithelium and limbus; WET=as WE but with TGF-β1 added at 10 ng/ml; WT=wounded after prior removal 
of the epithelium and limbus plus TGF-β1 added at 10 ng/ml), keratocyte activation (see arrows) and stromal disorganization were assessed 
with HPS staining (scale bars: 100 µm (row 1), 50 µm (row 2)), expression of α-smooth muscle actin (SMA), fibronectin (FN), tenascin C 
(TNC), and thrombospondin-1 (TSP) with immunofluorescence (scale bars=100 µm), and corneal opacity (OP) by the ability to read Arial 
8 characters (number of opaque corneas / total number of corneas examined for each condition). Each figure shows the wound region only, 
except the control E, which shows the central part of the cornea.
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(Figure 3B, Figure 5) compared to controls, as found in the 
air-liquid culture. Keratocyte activation and stromal disor-
ganization were also seen (though with less stromal disor-
ganization than in the A/L conditions), and fibronectin 
and tenascin C were strongly expressed, comparable to the 
IM/WET condition. Thrombospondin-1 was also highly 
expressed, reaching statistical significance. Most strikingly, 
however, as with the air-liquid equivalent, most of the corneas 
were now opaque, as illustrated in Figure 4.
We also investigated changes in the expression of 
collagen III. Since we were unable to obtain a satisfactorily 
specific signal with immunofluorescence, despite using 
different antibodies, we measured collagen III expression 
with real-time PCR. Collagen III mRNA was 175.7±61.8-fold 
more abundant in the stroma of corneas cultured in the IM/
WT condition than in corneas cultured in the IM/E control 
condition.
Comparison of the air-liquid interface and immersed models: 
Using air-liquid and immersed culture, the models for which 
wound healing occurred in the presence of added TGF-β1 
and in the absence of the epithelium/limbus led to the most 
severe scars, characterized by corneal opacity, keratocyte 
activation, and stromal disorganization, with marked expres-
sion of α-SMA, fibronectin, tenascin C, and collagen III 
(immersed model). When the results of the semiquantitative 
analyses were compared, between control conditions (E) and 
those without epithelium plus TGF-β1 (WT), the same trends 
were apparent in the air-liquid and immersed cultures (Figure 
3C). There were no significant differences between AL/E and 
IM/E, or between AL/WT and IM/WT, except in the case 
of α-SMA for which more intense staining was observed 
in the IM/WT condition compared to AL/WT. In conclu-
sion, air-liquid and immersed cultures appeared suitable for 
reproducing most of the events of corneal scar formation 
after injury. A summary of the main findings of this study is 
shown in Table 1.
DISCUSSION
Using human corneas cultured in ex vivo conditions, we 
preserved the histological quality of the control corneas, for 
both the stroma and the epithelium, in the air-liquid configu-
ration and for the stroma only in the immersed configuration, 
as well as their transparency. Importantly, we reproduced the 
loss of transparency observed in patients when corneas were 
wounded, after prior removal of the epithelium and limbus, 
and then cultured in the presence of added TGF-β1. Analysis 
of the expression of several extracellular proteins, combined 
with histological characterization, demonstrated the ability of 
Table 1. Summary of The main findingS preSenTed in ThiS STudy.
Air/liquid conditions Epithelium/
limbus preserved, 
unwounded
Epithelium/
limbus 
preserved, 
wounded
Epithelium/limbus 
preserved, wounded, 
TGF-β1
Epithelium/limbus removed, 
wounded, TGF- β1
Keratocyte activation, 
stromal disorganization
- + ++ ++
Myofibroblast differentia-
tion (α-SMA)
- - + +
ECM production 
(fibronectin, tenascin C, 
thrombospondin-1)
- + ++ ++
Corneal opacity - - - +
Immersed conditions Epithelium/
limbus preserved, 
unwounded
Epithelium/
limbus 
preserved, 
wounded
Epithelium/limbus 
preserved, wounded, 
TGF- β1
Epithelium/limbus removed, 
wounded, TGF- β1
Keratocyte activation, 
stromal disorganization
- - + +
Myofibroblast differentia-
tion (α-SMA)
- - + +
ECM production 
(fibronectin, tenascin C, 
thrombospondin-1)
- + ++ ++
Corneal opacity - - - +
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the models to reproduce corneal scarring in terms of stromal 
disorganization, keratocyte proliferation, differentiation into 
myofibroblasts, and enhanced synthesis of provisional extra-
cellular matrix components, especially fibronectin, tenascin 
C, and collagen III (albeit that the latter was detected only at 
the RNA level). As we used intact human corneas for these 
studies, the models described here are closer to the in vivo 
situation than the three-dimensional cell culture models 
reported in the literature [41,42]. Our models also extend 
previous ex vivo models [29-35] through the use of additional 
wound healing markers. Most importantly, to our knowledge, 
this is also the first time that a loss of transparency has been 
reported in an in vitro model. Although further optimiza-
tion is possible, for example, by adding other inflammatory 
cytokines or fine-tuning the time scale of the ex vivo culture, 
these models already represent valuable tools for studying 
wound healing and for testing various compounds that might 
affect, positively or negatively, the healing process.
As expected, we found that wounding alone was not suffi-
cient to trigger the scarring process in human ex vivo corneas, 
even though keratocyte activation and limited synthesis of 
fibronectin and tenascin C were already observed. Since this 
limited response was linked to the absence of inflammatory 
cells (normally infiltrating the wound from the limbus and 
from tear fluid), we added TGF-β1, the most well-known 
and widely used fibrogenic growth factor. As expected, this 
resulted in the appearance of α-SMA expression (albeit weak), 
in air-liquid and immersed conditions. Only when regenera-
tion of the epithelium after wounding was prevented by prior 
removal of the epithelium and limbus was it possible to obtain 
opaque scar-like tissue. This is consistent with the known 
role of the epithelium in preventing scar formation [9]. These 
observations also suggest that regenerating the epithelium 
creates a barrier preventing diffusion of exogenous TGF-β1.
During the course of this study, different concentrations 
of TGF-β1 were tested. At low concentrations (1–2 ng/ml), 
no corneal opacity was observed (data not shown). Only at 
a concentration of 10 ng/ml did the corneas become opaque 
(in the absence of the epithelium). The choice of optimum 
TGF-β concentration has been discussed in the context of 
corneal keratocyte culture models [41,43], where 0.25 to 1 ng/
ml was optimal. Higher doses (10 ng/ml) led to contraction 
of keratocyte culture sheets [41,44], as found when cells were 
cultured in collagen gels [45]. These reports raise the ques-
tion of whether the opacity observed here, when the corneas 
were cultured in the presence of 10 ng/ml TGF-β and in the 
absence of the epithelium and limbus, could be due at least 
partly to retraction. Retraction might have occurred to some 
extent, as sometimes the final diameter of the corneas was 
less than that of the trepan (8 mm) used to isolate the central 
region (Figure 4). Though this parameter was not measured 
systematically, such effects were probably relatively small. 
The fact that this was not observed when intact corneas 
were used may be due to the extra rigidity provided by the 
surrounding scleral tissue.
Since the main objective of this study was generating 
stable corneal haze, we did not analyze stromal parameters 
on shorter time scales, though it is likely that our models 
could also provide useful information concerning the early 
steps of the healing process. Notably, it would certainly be 
informative to analyze the corneas that retained their epithe-
lium, just before complete reepithelialization (5–6 days 
after wounding in our models) when the switch between 
inflammatory and “granulation” phases occurs in vivo and 
when epithelial-stromal interactions are maximal. Throm-
bospondin-1 especially might be expressed at a higher level 
as has been described in vivo after corneal injury [21,46]. 
In addition, since TGF-β2 plays a major role in controlling 
epithelial-stromal interactions during corneal repair [10], 
comparing TGF-β1 and TGF-β2 for their ability to promote 
a scar-like evolution of the wounded corneas would be inter-
esting. Adding other fibrogenic cytokines (PDGF, CTGF, 
etc.) could also influence the scarring process and could be 
included in these models.
Although the link between haze and an abnormal repair 
process is clearly established, the mechanisms responsible 
for the loss of transparency are less well understood. In 
the models described here, two main parameters may have 
contributed to the loss of transparency: (i) the increased 
number of cells with altered morphology and altered refrac-
tive properties and (ii) the deposition of an excess of extra-
cellular matrix molecules with inappropriate organization. 
Concerning the first parameter, changes in cell content 
and reduced expression of corneal crystallins observed 
in myofibroblasts compared to quiescent keratocytes has 
been shown to reduce corneal transparency [47,48]. More 
complex to analyze are the amount and architecture of the 
newly deposited extracellular matrix since, in the cornea, 
excessive matrix deposition has never been clearly linked 
to scarring as in skin, for example. Since there is no direct 
relationship between the apparent disorganization of collagen 
fibers and the persistence of corneal haze, however, increased 
keratocyte activation and disruption of the subepithelial layer 
seem to be the major contributory factors [49-51]. Further 
studies with transmission electron microscopy are required 
to address these questions.
Although the air-liquid interface and immersed models 
can reproduce corneal scarring, they also have specific 
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advantages and disadvantages. The expression of some of 
the markers seemed higher in the immersed model; however, 
these increases proved statistically significant only for 
α-SMA. Nonetheless, perfusion of the cornea with soluble 
products (including growth factors and pharmacological 
agents) is expected to be more efficient in this model. In 
contrast, culture at the air-liquid interface maintains the 
differentiated epithelium and is closer to the in vivo situation. 
In addition, topical application of creams and other insoluble 
formulations could be tested in this model.
In conclusion, we have developed two ex vivo models 
of human corneal wound healing that (albeit different from 
the in vivo situation) can be used to reproduce many of the 
features of corneal scarring. The expression of other stromal 
proteins involved in wound healing can now be analyzed in 
more detail to confirm trends observed in animal models. In 
addition, soluble and insoluble products can be easily tested 
as well as innovative therapeutic treatments (drugs, proteins, 
small interfering RNAs, autologous limbal stem cells, etc.).
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